Saturday, September 6th
Search EmpowHer  
     

Armed with a lifetime of experiences, women are drawn to the doorway from which the light shines to SHARE with women in need.

To share your own story, simply click on this button:

From this page you can share Researchers Report Doctors Discover Marker for Meconium Passage During Delivery to a social bookmarking site or email a link to the page.
Social WebE-mail
Enter multiple addresses on separate lines or separate them with commas.
(Your Name) has forwarded a page to you from EmpowHer
(Your Name) thought you would like to see this page from the EmpowHer web site.
     
hernews's picture

Researchers Report Doctors Discover Marker for Meconium Passage During Delivery

54
vote
     
     

By Amanda Gardner
EmpowHer's HealthDay Reporter

TUESDAY, May 6 (HealthDay News) -- Researchers report they have identified a marker that might predict which pregnant women will pass meconium during delivery.

Meconium is essentially a baby's first bowel movement, excreted in the womb, and often expelled with the amniotic fluid. It is considered a sign of fetal distress. A small percentage of newborns inhale a mixture of meconium and amniotic fluid, which can lead to serious lung injury or infection.

"Meconium in and of itself is not necessarily a bad thing," Dr. Jennifer Wu, an obstetrician/gynecologist at Lenox Hill Hospital in New York City, explained. "It's a bad thing when you have meconium complications like aspiration. It's like being born with the umbilical cord around the neck. Twenty-five percent of babies are born this way, but for most of them, it's not a big deal. It's the same thing for meconium. Only a small number of [babies born with] meconium-stained fluid actually aspirate."

In fact, 11 percent of babies aspirate meconium-stained fluid, but the situation is not dire in all cases.

It's unclear how this latest finding will actually help physicians and expectant mothers during delivery.

"At this point, I don't know what we're going to do with this data," said Wu. "It's not like you would do anything differently or perform a C-section. We need additional studies in order to find a clinical intervention that can help."

The findings were expected to be presented Tuesday at the American College of Obstetricians and Gynecologists annual meeting, in New Orleans.

For this study, researchers from Lincoln Medical Center in the Bronx, N.Y., drew blood to measure levels of a hormone, inhibin-A, in 19 pregnant women who had had a normal pregnancy and delivery.

Inhibin-A levels were higher in four women who had normal pregnancies but who passed meconium during delivery. The test was conducted during the second trimester.